Plasma and urine GOAT levels were found to correlate with presence of metastases and molecular markers of tumor aggressiveness, suggesting that this may be a non-invasive means of predicting prostate cancer aggressiveness [51,52,53]. Here, MBOAT4 is linked to prostate carcinoma.